About B. (Bram) Dierckx, MD, PhD
Introduction
I am a child and adolescent psychiatrist, clinical pharmacologist, and assistant professor at the Department of Child and Adolescent Psychiatry/Psychology at Erasmus Medical Centre in Rotterdam. I obtained my PhD in 2012 from the same department.
My clinical and academic focusses on psychopharmacology in child psychiatry, with a research focus on the safety, effectiveness, and personalized dosing of psychiatric medications in youth. I lead and collaborate on several national and international projects investigating antipsychotic pharmacokinetics and therapeutic drug monitoring. I am also involved in serious gaming and virtual reality projects aimed at improving psychosocial care for children in a hospital setting.
In recent years, I have secured multiple grants as principal investigator for projects ranging from serious gaming in pediatric oncology to international randomized trials optimizing risperidone and aripiprazole treatment in children with autism. I currently supervise several PhD candidates on research involving antipsychotic safety and digital health innovations.
As a member of the Kenniscentrum KJP Psychofarmaca and the Kinderformularium, I contribute to national guidance on pediatric psychotropic use. I am also involved in postgraduate teaching in psychopharmacology, and co-authored textbook chapters on pediatric psychopharmacology.
My clinical and academic focusses on psychopharmacology in child psychiatry, with a research focus on the safety, effectiveness, and personalized dosing of psychiatric medications in youth. I lead and collaborate on several national and international projects investigating antipsychotic pharmacokinetics and therapeutic drug monitoring. I am also involved in serious gaming and virtual reality projects aimed at improving psychosocial care for children in a hospital setting.
In recent years, I have secured multiple grants as principal investigator for projects ranging from serious gaming in pediatric oncology to international randomized trials optimizing risperidone and aripiprazole treatment in children with autism. I currently supervise several PhD candidates on research involving antipsychotic safety and digital health innovations.
As a member of the Kenniscentrum KJP Psychofarmaca and the Kinderformularium, I contribute to national guidance on pediatric psychotropic use. I am also involved in postgraduate teaching in psychopharmacology, and co-authored textbook chapters on pediatric psychopharmacology.
Education and career
Clinical pharmacologist EMC 2014-2016
Phd EMC 2005-2014
CA psychiatrist EMC 2008-2012
Medical doctor UIA 1999-2003
Phd EMC 2005-2014
CA psychiatrist EMC 2008-2012
Medical doctor UIA 1999-2003
Publications
Find an overview of my publications here.
Teaching activities
- Assistant professor
- Supervised theses of Sanne Kloosterboer and Robin Eijlers.
- Currently supervising theses of Kajie Liang, Lisa Ringeling, Ravish Gangapersad, Rebecca Hermans, Louise Meulenkamp and Souraya El Bardai.
- Involved with Masterclass Psychopharmacology in Child and Adolescent Psychiatry
- Deputy chair for the child psychiatry residency program at Erasmus MC.
Other positions
- Member of the Kinderformularium
- Member of the Medication Commission of the National Knowledge Center For Child and Adolescent Psychiatry
Scholarships, grants, and awards
Grants received:
- Erasmus University Grant for SPECIAL – risk factors associated with antipsychotic use.
- Erasmus MC, department of pharmacy Grant for Torpedo – olanzapine pharmacokinetics in adolescents with AN.
- RTL project Glimlach and Vrienden van Sophia Grants for VR exposure before elective pediatric day-care surgery.
- Roparun Grant For My new me. A serious gaming invervention.
- Stichting Coolsingel and SSWO Grants for VR exposure before MRI.
- Stichting Theia and Stichting Coolsingel Grants for VR exposure before elective pediatric day-care surgery.
- ZoMW GG Grant for Safety and pharmacokinetics of antipsychotics in children.
- SSWO Grant for Unraveling Autism in Children with Fragile X Syndrome.